203 related articles for article (PubMed ID: 22848769)
1. Pharmacology of DB844, an orally active aza analogue of pafuramidine, in a monkey model of second stage human African trypanosomiasis.
Thuita JK; Wang MZ; Kagira JM; Denton CL; Paine MF; Mdachi RE; Murilla GA; Ching S; Boykin DW; Tidwell RR; Hall JE; Brun R
PLoS Negl Trop Dis; 2012; 6(7):e1734. PubMed ID: 22848769
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the novel diamidine compound 2,5-Bis(4-amidinophenyl)- furan-bis-O-Methlylamidoxime (Pafuramidine, DB289) against Trypanosoma brucei rhodesiense infection in vervet monkeys after oral administration.
Mdachi RE; Thuita JK; Kagira JM; Ngotho JM; Murilla GA; Ndung'u JM; Tidwell RR; Hall JE; Brun R
Antimicrob Agents Chemother; 2009 Mar; 53(3):953-7. PubMed ID: 19064893
[TBL] [Abstract][Full Text] [Related]
3. In vitro metabolism of an orally active O-methyl amidoxime prodrug for the treatment of CNS trypanosomiasis.
Ansede JH; Voyksner RD; Ismail MA; Boykin DW; Tidwell RR; Hall JE
Xenobiotica; 2005 Mar; 35(3):211-26. PubMed ID: 16019947
[TBL] [Abstract][Full Text] [Related]
4. New treatment option for second-stage African sleeping sickness: in vitro and in vivo efficacy of aza analogs of DB289.
Wenzler T; Boykin DW; Ismail MA; Hall JE; Tidwell RR; Brun R
Antimicrob Agents Chemother; 2009 Oct; 53(10):4185-92. PubMed ID: 19620327
[TBL] [Abstract][Full Text] [Related]
5. Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis.
Thuita JK; Wolf KK; Murilla GA; Liu Q; Mutuku JN; Chen Y; Bridges AS; Mdachi RE; Ismail MA; Ching S; Boykin DW; Hall JE; Tidwell RR; Paine MF; Brun R; Wang MZ
PLoS Negl Trop Dis; 2013; 7(6):e2230. PubMed ID: 23755309
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis.
Yang S; Wenzler T; Miller PN; Wu H; Boykin DW; Brun R; Wang MZ
Antimicrob Agents Chemother; 2014 Jul; 58(7):4064-74. PubMed ID: 24798280
[TBL] [Abstract][Full Text] [Related]
7. Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes.
Mathis AM; Holman JL; Sturk LM; Ismail MA; Boykin DW; Tidwell RR; Hall JE
Antimicrob Agents Chemother; 2006 Jun; 50(6):2185-91. PubMed ID: 16723581
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of second stage human African trypanosomiasis: comparison between the parenteral diamidine DB829 and its oral prodrug DB868 in vervet monkeys.
Thuita JK; Wolf KK; Murilla GA; Bridges AS; Boykin DW; Mutuku JN; Liu Q; Jones SK; Gem CO; Ching S; Tidwell RR; Wang MZ; Paine MF; Brun R
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003409. PubMed ID: 25654243
[TBL] [Abstract][Full Text] [Related]
9. Influence of trypanocidal therapy on the haematology of vervet monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Ngotho M; Kagira JM; Kariuki C; Maina N; Thuita JK; Mwangangi DM; Farah IO; Hau J
Acta Trop; 2011 Jul; 119(1):14-8. PubMed ID: 21420376
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, Safety, and Dose of Pafuramidine, a New Oral Drug for Treatment of First Stage Sleeping Sickness, in a Phase 2a Clinical Study and Phase 2b Randomized Clinical Studies.
Burri C; Yeramian PD; Allen JL; Merolle A; Serge KK; Mpanya A; Lutumba P; Mesu VK; Bilenge CM; Lubaki JP; Mpoto AM; Thompson M; Munungu BF; Manuel F; Josenando T; Bernhard SC; Olson CA; Blum J; Tidwell RR; Pohlig G
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004362. PubMed ID: 26881924
[TBL] [Abstract][Full Text] [Related]
11. Diamidines for human African trypanosomiasis.
Paine MF; Wang MZ; Generaux CN; Boykin DW; Wilson WD; De Koning HP; Olson CA; Pohlig G; Burri C; Brun R; Murilla GA; Thuita JK; Barrett MP; Tidwell RR
Curr Opin Investig Drugs; 2010 Aug; 11(8):876-83. PubMed ID: 20721830
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Pafuramidine versus Pentamidine Maleate for Treatment of First Stage Sleeping Sickness in a Randomized, Comparator-Controlled, International Phase 3 Clinical Trial.
Pohlig G; Bernhard SC; Blum J; Burri C; Mpanya A; Lubaki JP; Mpoto AM; Munungu BF; N'tombe PM; Deo GK; Mutantu PN; Kuikumbi FM; Mintwo AF; Munungi AK; Dala A; Macharia S; Bilenge CM; Mesu VK; Franco JR; Dituvanga ND; Tidwell RR; Olson CA
PLoS Negl Trop Dis; 2016 Feb; 10(2):e0004363. PubMed ID: 26882015
[TBL] [Abstract][Full Text] [Related]
13. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.
Priotto G; Kasparian S; Mutombo W; Ngouama D; Ghorashian S; Arnold U; Ghabri S; Baudin E; Buard V; Kazadi-Kyanza S; Ilunga M; Mutangala W; Pohlig G; Schmid C; Karunakara U; Torreele E; Kande V
Lancet; 2009 Jul; 374(9683):56-64. PubMed ID: 19559476
[TBL] [Abstract][Full Text] [Related]
14. Trypanosoma brucei rhodesiense transmitted by a single tsetse fly bite in vervet monkeys as a model of human African trypanosomiasis.
Thuita JK; Kagira JM; Mwangangi D; Matovu E; Turner CM; Masiga D
PLoS Negl Trop Dis; 2008; 2(5):e238. PubMed ID: 18846231
[TBL] [Abstract][Full Text] [Related]
15. A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.
Kansiime F; Adibaku S; Wamboga C; Idi F; Kato CD; Yamuah L; Vaillant M; Kioy D; Olliaro P; Matovu E
Parasit Vectors; 2018 Feb; 11(1):105. PubMed ID: 29471865
[TBL] [Abstract][Full Text] [Related]
16. IL-6 is upregulated in late-stage disease in monkeys experimentally infected with Trypanosoma brucei rhodesiense.
Nyawira Maranga D; Kagira JM; Kinyanjui CK; Muturi Karanja S; Wangari Maina N; Ngotho M
Clin Dev Immunol; 2013; 2013():320509. PubMed ID: 24194772
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of Nifurtimox Eflornithine Combination Therapy (NECT) in T. b. gambiense second stage sleeping sickness patients in the Democratic Republic of Congo: Report from a field study.
Kuemmerle A; Schmid C; Bernhard S; Kande V; Mutombo W; Ilunga M; Lumpungu I; Mutanda S; Nganzobo P; Tete DN; Kisala M; Burri C; Blesson S; Valverde Mordt O
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009903. PubMed ID: 34748572
[TBL] [Abstract][Full Text] [Related]
18. Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein.
Sanderson L; Dogruel M; Rodgers J; De Koning HP; Thomas SA
J Pharmacol Exp Ther; 2009 Jun; 329(3):967-77. PubMed ID: 19261919
[TBL] [Abstract][Full Text] [Related]
19. CYP1A1 and CYP1B1-mediated biotransformation of the antitrypanosomal methamidoxime prodrug DB844 forms novel metabolites through intramolecular rearrangement.
Ju W; Yang S; Ansede JH; Stephens CE; Bridges AS; Voyksner RD; Ismail MA; Boykin DW; Tidwell RR; Hall JE; Wang MZ
J Pharm Sci; 2014 Jan; 103(1):337-49. PubMed ID: 24186380
[TBL] [Abstract][Full Text] [Related]
20. Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.
Mesu VKBK; Kalonji WM; Bardonneau C; Mordt OV; Blesson S; Simon F; Delhomme S; Bernhard S; Kuziena W; Lubaki JF; Vuvu SL; Ngima PN; Mbembo HM; Ilunga M; Bonama AK; Heradi JA; Solomo JLL; Mandula G; Badibabi LK; Dama FR; Lukula PK; Tete DN; Lumbala C; Scherrer B; Strub-Wourgaft N; Tarral A
Lancet; 2018 Jan; 391(10116):144-154. PubMed ID: 29113731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
